Ebola virus vaccines: Where do we stand?-Reference-Cited by-同舟云学术

Ebola virus vaccines: Where do we stand?

Published:2016-12 Issue: Volume:173 Page:44-49
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Pavot Vincent^ORCID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. Ebola virus disease;Beeching;BMJ,2014

2. 2014 Ebola Outbreak in West Africa - Case Counts|Ebola Hemorrhagic Fever|CDC, (n.d.). http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html (accessed September 20, 2016).

3. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses;Jones;Nat. Med.,2005

4. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge;Stanley;Nat. Med.,2014

5. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule;Sullivan;Nat. Rev. Microbiol.,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections;Asian Pacific Journal of Tropical Medicine;2024-07

2. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: A state of arts review;Journal of Medical Virology;2023-08

3. Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges;Vaccines;2023-01-26

4. EnhancedIn VitroandIn VivoPotency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions;Journal of Virology;2022-09-28

5. Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model;Emerging Microbes & Infections;2021-01-01